168 related articles for article (PubMed ID: 12950176)
1. Binding and inhibition of Cdc25 phosphatases by vitamin K analogues.
Kar S; Lefterov IM; Wang M; Lazo JS; Scott CN; Wilcox CS; Carr BI
Biochemistry; 2003 Sep; 42(35):10490-7. PubMed ID: 12950176
[TBL] [Abstract][Full Text] [Related]
2. Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK.
Kar S; Wang M; Ham SW; Carr BI
Biochem Pharmacol; 2006 Nov; 72(10):1217-27. PubMed ID: 16930563
[TBL] [Abstract][Full Text] [Related]
3. K vitamins, PTP antagonism, and cell growth arrest.
Carr BI; Wang Z; Kar S
J Cell Physiol; 2002 Dec; 193(3):263-74. PubMed ID: 12384979
[TBL] [Abstract][Full Text] [Related]
4. Cdc25 inhibition and cell cycle arrest by a synthetic thioalkyl vitamin K analogue.
Tamura K; Southwick EC; Kerns J; Rosi K; Carr BI; Wilcox C; Lazo JS
Cancer Res; 2000 Mar; 60(5):1317-25. PubMed ID: 10728693
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Cdc25A phosphatase in Hep3B hepatoma cell growth inhibition induced by novel K vitamin analogs.
Wang Z; Southwick EC; Wang M; Kar S; Rosi KS; Wilcox CS; Lazo JS; Carr BI
Cancer Res; 2001 Oct; 61(19):7211-6. PubMed ID: 11585757
[TBL] [Abstract][Full Text] [Related]
6. Modulation of bcl-2 family proteins in MAPK independent apoptosis induced by a cdc25 phosphatase inhibitor Cpd 5 in renal cancer cells.
Mizuno R; Oya M; Hara S; Matsumoto M; Horiguchi A; Ohigashi T; Marumo K; Murai M
Oncol Rep; 2005 Sep; 14(3):639-44. PubMed ID: 16077967
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell growth inhibition and extracellular signal-regulated kinase (ERK) phosphorylation by novel K vitamins.
Osada S; Osada K; Carr BI
J Mol Biol; 2001 Dec; 314(4):765-72. PubMed ID: 11733995
[TBL] [Abstract][Full Text] [Related]
9. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis.
Kar S; Wang M; Carr BI
Cancer Chemother Pharmacol; 2008 Oct; 62(5):831-40. PubMed ID: 18246350
[TBL] [Abstract][Full Text] [Related]
10. Cdc25A and ERK interaction: EGFR-independent ERK activation by a protein phosphatase Cdc25A inhibitor, compound 5.
Wang Z; Zhang B; Wang M; Carr BI
J Cell Physiol; 2005 Aug; 204(2):437-44. PubMed ID: 15672448
[TBL] [Abstract][Full Text] [Related]
11. Flexibility and inhibitor binding in cdc25 phosphatases.
Arantes GM
Proteins; 2010 Nov; 78(14):3017-32. PubMed ID: 20740493
[TBL] [Abstract][Full Text] [Related]
12. EGFR-independent activation of ERK1/2 mediates growth inhibition by a PTPase antagonizing K-vitamin analog.
Kar S; Adachi T; Carr BI
J Cell Physiol; 2002 Mar; 190(3):356-64. PubMed ID: 11857451
[TBL] [Abstract][Full Text] [Related]
13. Identification of a C-terminal cdc25 sequence required for promotion of germinal vesicle breakdown.
Powers EA; Thompson DP; Garner-Hamrick PA; He W; Yem AW; Bannow CA; Staples DJ; Waszak GA; Smith CW; Deibel MR; Fisher C
Biochem J; 2000 May; 347 Pt 3(Pt 3):653-60. PubMed ID: 10769167
[TBL] [Abstract][Full Text] [Related]
14. PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo.
Kar S; Wang M; Yao W; Michejda CJ; Carr BI
Mol Cancer Ther; 2006 Jun; 5(6):1511-9. PubMed ID: 16818510
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review.
Lavecchia A; Di Giovanni C; Novellino E
Expert Opin Ther Pat; 2010 Mar; 20(3):405-25. PubMed ID: 20166845
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition and protein tyrosine phosphorylation in MCF 7 breast cancer cells by a novel K vitamin.
Kar S; Carr BI
J Cell Physiol; 2000 Dec; 185(3):386-93. PubMed ID: 11056008
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Cdc25 phosphatases by indolyldihydroxyquinones.
Sohn J; Kiburz B; Li Z; Deng L; Safi A; Pirrung MC; Rudolph J
J Med Chem; 2003 Jun; 46(13):2580-8. PubMed ID: 12801222
[TBL] [Abstract][Full Text] [Related]
18. H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERK.
Kar S; Wang M; Ham SW; Carr BI
Cancer Biol Ther; 2006 Oct; 5(10):1340-7. PubMed ID: 16969075
[TBL] [Abstract][Full Text] [Related]
19. The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C.
Bachmann M; Kosan C; Xing PX; Montenarh M; Hoffmann I; Möröy T
Int J Biochem Cell Biol; 2006 Mar; 38(3):430-43. PubMed ID: 16356754
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of the CDC25 phosphatases.
Prevost GP; Brezak MC; Goubin F; Mondesert O; Galcera MO; Quaranta M; Alby F; Lavergne O; Ducommun B
Prog Cell Cycle Res; 2003; 5():225-34. PubMed ID: 14593717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]